SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending sharply higher, fueled by optimism surrounding the appointment of a new CEO from Shopify and the return of founders to the board, with the community discussing the potential for a short squeeze and comparing the move to Carvana's recovery. Discussions revolve around breaching the $10 mark and the stock's potential for significant further gains, with some referencing the CEO's incentive-based compensation as a positive catalyst. The stock's high short interest is adding fuel to the fire.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's stock is trending amid debates over its valuation and future prospects, with community members discussing potential breakouts above $360 and the impact of Elon Musk's leadership. Discussions range from the company's position in the EV market, competition in robo-taxis, and the potential impact of Optimus robots, with some questioning if current pricing is justified.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amidst a swirl of political commentary following news of a shooting involving Charlie Kirk, sparking heated debates within the community. Discussions range from accusations and counter-accusations between political factions to broader concerns about violence and rhetoric. Some users are also referencing the Epstein files, potentially linking them to the current events.

Wearable Devices Ltd. engages in the development of a non-invasive neural input technology that allows operation and control of digital devices using subtle finger movements and fingertip pressure. It offers Mudra band, a neutral input wristband. The company was founded by Asher Dahan, Guy Wagner, and Leeor Langer in March 2014 and is headquartered in Yokne'am Illit, Israel.

Wearable Devices Ltd

Wearable Devices is trending due to a recently secured U.S. patent for its gesture and voice-controlled interface device, sparking excitement around its potential in AI and neural interface technology. The community is actively discussing the possibility of a buyout by a major tech player like Apple, along with potential short squeezes given the stock's low float and high trading volume.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

CRCL is trending as the community discusses a potential pump and dump scenario, with some pointing to an upcoming share release as a catalyst. Bullish sentiment focuses on the stock's bounce and potential for higher price targets, while bears highlight concerns around interest rate cuts and insider selling. Overall, traders are actively debating the stock's short-term volatility and long-term prospects within the crypto and fintech landscape.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending as Citigroup raised its price target, citing expectations for strong earnings and increased DRAM and NAND sales, fueling optimism for the company's outlook. The community is actively discussing the potential for new all-time highs and comparing Micron's growth prospects to other major players in the semiconductor space. Bullish sentiment surrounds Micron's role in AI and data centers, with some anticipating a significant rally.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is trending as community members discuss a potential short squeeze and speculate on price movements, with some drawing comparisons to past rallies. Bullish sentiment is fueled by the company's AI data center initiatives, while others remain cautious due to the stock's historical volatility and correlation to crypto markets. The community is closely watching for a breakout above key resistance levels.

Mogu, Inc. operates an online fashion and lifestyle destination platform. Its platform features live video broadcasts, short-form videos, photographs, and articles covering topics such as product reviews, fashion tips, brand fitting rooms, celebrity appearances, and street fashion. The company caters to fashion and beauty needs, offering products including apparel, beauty and personal care items, food, and medical beauty products. It also provides online marketing, commission services, financing, technology solutions, and other related services to merchants and users. Mogu was founded by Qi Chen, Xuqiang Yue, and Yibo Wei on June 9, 2011 and is headquartered in Hangzhou, China.

MOGU Inc - ADR

MOGU Inc.

MOGU is trending due to the announcement of a significant share repurchase program, sparking community discussion about its potential impact on the stock price and float. Some traders are optimistic about a potential squeeze, while others remain cautious, pointing to the company's history and the risks associated with Chinese stocks. The stock's low float and high premarket volume are also contributing to its current buzz.

Silexion Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the discovery and development of treatments for KRAS-driven cancers. The company was founded on November 30, 2008 and is headquartered in in Modiin, Israel.

Silexion Therapeutics Corp

Silexion Therapeutics Ltd

Silexion Therapeutics is trending after announcing positive preclinical data for its cancer drug, SIL204, showcasing efficacy against metastatic pancreatic cancer; however, a concurrent public offering appears to be tempering community enthusiasm, with some investors expressing concerns about potential dilution. Discussions revolve around the stock's potential to revisit previous highs and the impact of the recent data on its long-term prospects in the biotech sector. Traders are closely watching for potential trading opportunities, including short squeezes.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as chatter increases around its potential role in AI data centers and its partnership with Nvidia. The community is closely watching the new CEO and speculating about potential news or a possible acquisition. Discussions also include recent insider selling and its potential impact.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$IFRX Presenting here educates this niche on vilobelimab&#39;s tolerability (no new signals in the trial) and activity, fostering KOL relationships or off-label interest. It differentiates InflaRx from competitors in the complement space (e.g., AstraZeneca&#39;s Alexion assets) by $AZN showing skin-specific applications, without committing resources to cSCC development. If the long-term survivor data includes updated imaging or biomarkers (e.g., reduced C5a-driven inflammation), it could spark collaborations for investigator-initiated trials in other dermatologic cancers.

In summary, this showcase is less about advancing cSCC as a franchise and more about leveraging existing data for scientific impact, partnership allure, and pipeline validation in a dermatology hub. It&#39;s a low-cost way to keep vilobelimab top-of-mind, especially with upcoming catalysts like INF904 data. If InflaRx&#39;s pipeline evolves (e.g., via partnerships), cSCC could resurface, but for now, it&#39;s strategic storytelling.

Marcel G.

FlowerInTheCellar

Brandon Sydor

CIELO1

Green_Dream

avalon E

GMSinvest

StartSlow

test

StockTwits for iOS

InflaRx N.V.

AstraZeneca PLC

 Presenting here educates this niche on vilobelimab's tolerability (no new signals in the trial) and activity, fostering KOL relationships or off-label interest. It differentiates InflaRx from competitors in the complement space (e.g., AstraZeneca's Alexion assets) by 

 showing skin-specific applications, without committing resources to cSCC development. If the long-term survivor data includes updated imaging or biomarkers (e.g., reduced C5a-driven inflammation), it could spark collaborations for investigator-initiated trials in other dermatologic cancers.

In summary, this showcase is less about advancing cSCC as a franchise and more about leveraging existing data for scientific impact, partnership allure, and pipeline validation in a dermatology hub. It's a low-cost way to keep vilobelimab top-of-mind, especially with upcoming catalysts like INF904 data. If InflaRx's pipeline evolves (e.g., via partnerships), cSCC could resurface, but for now, it's strategic storytelling.